Antibody Therapeutics Market Size, Strategic Analysis, Growth Drivers, Industry Trends, Demand and Future Opportunities and Forecast Period
The antibody
therapeutics market is anticipated to reach USD XXX.X million by 2034
from USD XXX.X million in 2023, at a CAGR of XX.X% during the forecast period
2024-2034.
A class of
biologic medications known as antibody therapeutics uses engineered,
monoclonal, polyclonal, or other antibodies to treat, diagnose, or prevent
disease. The target antigens for these antibodies are typically proteins that
are mostly found on the surface of pathogens, cancerous cells, or damaged
cells. Therefore, therapeutic antibodies can send cytotoxic substances directly
to damaged tissues, trigger the immune system to assault the targeted cells, or
target the antigens and neutralize the threat.
Request For Free Sample Pages @ https://www.xresearch.biz/request-sample-pages/antibody-therapeutics-market
Growth
Drivers:
There are many
candidates in different phases of clinical development, and the pipeline for
antibody therapies is growing quickly. For example, as of January 2024, the
Antibody Society reports that over 850 antibody therapies for cancer
indications are in active pipeline. They accomplish this growth by increasing
R&D and investing in novel therapeutic targets.
The biological
characteristics of the described antibodies have hampered the effectiveness and
specificity of antibody therapies. Recombinant DNA technology and
bioinformatics are two methods used to advance the creation of monoclonal
antibodies with better pharmacokinetics and decreased immunogenicity.
Additionally, bispecific antibodies have the same benefits of accuracy and
therapeutic usefulness due to their ability to bind two targets simultaneously.
Antibody
Therapeutics market Segmentation:
By Type:
· Polyclonal
Antibodies
· Monoclonal
Antibodies
· Bispecific
Antibodies
· Antibody
Fragments
· Antibody-Drug
Conjugates
· Others
By Disease Area:
· Oncology
· Neurology
· Immunology
· Infectious
Diseases
· Autoimmune
& Inflammatory Diseases
· Hematology
· Osteology
· Others
By Source:
· Human
· Humanized
· Chimeric
· Others
By Route of Administration:
· Intravenous
· Subcutaneous
· Others
By End-User:
· Hospitals
· Long-Term
Care Facilities
· Specialty
Centers
· Others
By
Region:
· North
America
· Europe
· Asia
Pacific
· Latin
America
· Middle
East and Africa
Key
Companies in Antibody Therapeutics Market:
The research
report offers a competitive analysis of prominent companies operating in the global
antibody therapeutics market. Some of the leading players profiled in
the market research report include:
· F.
Hoffmann-La Roche Ltd.
· AbbVie,
Inc.
· Johnson
& Johnson Services, Inc.
· Merck
KGaA
· Bristol-Myers
Squibb Company
· AstraZeneca
plc
· Sanofi
· Novartis
AG
· Regeneron
Pharmaceuticals, Inc.
· Amgen,
Inc.
· Pfizer
Inc.
· Biogen
· Takeda
Pharmaceutical Company Limited
· Other
Player’s
For More Information about this Report @
https://www.xresearch.biz/shop/antibody-therapeutics-market
About Us: -
xResearch
is a market research and consulting organization that uses unique data, expert
analysis, and new technologies to create trusted intelligence on industries.
Our research is focused on delivering an informed and impartial view on
essential market data of industry, and it is primarily driven by an in-depth
study covering the following parameters: Market Sizing and Forecasting, Market
Segmentation, Competitive Analysis, Strategic Assessment and Business
Modelling.
Contact:
Company Name: xResearch
Contact Person: James Lin
Email: sales@xresearch.biz
Phone: +1 718-619-8140
Websites: https://www.xresearch.biz/

Comments
Post a Comment